NCT00364286 2026-01-20Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)M.D. Anderson Cancer CenterPhase 2 Completed17 enrolled 5 charts
NCT03117751 2025-12-05Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and LymphomaSt. Jude Children's Research HospitalPhase 2/3 Active not recruiting790 enrolled
NCT00788125 2023-07-14Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsCity of Hope Medical CenterPhase 1/2 Terminated7 enrolled 9 charts
NCT00918463 2018-08-31A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Weill Medical College of Cornell UniversityPhase 2 Terminated2 enrolled 7 charts